Healthcare Industry News: lopinavir/ritonavir
News Release - October 18, 2007
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Source: Gilead Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.